SMMT
Summit Therapeutics·NASDAQ
--
--(--)
--
--(--)
2.31 / 10
Underperform
Technical rating is Underperform with a 2.31/10 score. MACD Death Cross, Golden Cross, RSI Overbought and Long Upper Shadow generate bearish pressure. No bullish signals appear, indicating a weak chart outlook.
Analysis Checks(0/4)
Long Upper Shadow
Score2.68/10
Win Rate41.18%
Hist. Signals34
Avg Return2.92%
Score2.68/10
Win Rate41.18%
Hist. Signals34
Avg Return2.92%
MACD Death Cross
Score4.56/10
Win Rate50.00%
Hist. Signals12
Avg Return1.92%
Score4.56/10
Win Rate50.00%
Hist. Signals12
Avg Return1.92%
RSI Overbought
Score1/10
Win Rate0.00%
Hist. Signals6
Avg Return-14.02%
Score1/10
Win Rate0.00%
Hist. Signals6
Avg Return-14.02%
MACD Golden Cross
Score1/10
Win Rate36.36%
Hist. Signals11
Avg Return-3.83%
Score1/10
Win Rate36.36%
Hist. Signals11
Avg Return-3.83%
Long Upper Shadow
Score2.68/10
Win Rate41.18%
Hist. Signals34
Avg Return2.92%
Score2.68/10
Win Rate41.18%
Hist. Signals34
Avg Return2.92%
RSI Overbought
Score1/10
Win Rate0.00%
Hist. Signals6
Avg Return-14.02%
Score1/10
Win Rate0.00%
Hist. Signals6
Avg Return-14.02%
MACD Death Cross
Score4.56/10
Win Rate50.00%
Hist. Signals12
Avg Return1.92%
Score4.56/10
Win Rate50.00%
Hist. Signals12
Avg Return1.92%
MACD Golden Cross
Score1/10
Win Rate36.36%
Hist. Signals11
Avg Return-3.83%
Score1/10
Win Rate36.36%
Hist. Signals11
Avg Return-3.83%
Technical Analysis of SMMT?
- SMMT presents a Underperform setup with a Technical Score of 2.31/10. Key technical indicators highlight an RSI of 66.88 and a MACD of 0.54, with the trend anchored by the 50-Day SMA at 15.79. Traders should monitor key support at 16.63 and resistance at 17.43.
